drugset / Trial / NCT06400056

Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis

NCT06400056

Phase 1 Unknown 30 enrolled Assiut University
NaSingle-groupOpen-labelDiagnostic

Summary

AIM OF WORK : 1. Detect the most common fungal strains that cause tinea capitis 2. Detect Different effectiveness of terbinafine in different cases 3. Detect the resistant strains. 4. Detect the mycological and the clinical cure rates upon using systemic terbinafine in treatment of tinea capitis

Timeline

Start
2024-05
Primary completion
2025-04
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Terbinafine Small molecule 125 mg Oral
Subject Terbinafine Small molecule 187.5 mg Oral
Subject Terbinafine Small molecule 250 mg Oral